Search


	Podcast:		UC Science Today
	Episode:		A new strategy for treating MS is in the works
	Category:		Science & Medicine
	Duration:		00:01:02
	Publish Date:		2017-02-26 18:00:00
	Description:		Researchers have found a new strategy for treating multiple sclerosis, which affects about 2 million people globally. This chronic disease is incurable and can paralyze the brain and spinal cord when the immune system attacks the body. The progressive form of the disease is especially dangerous. "And it is typically characterized by weakness and numbness in a leg, then spreading to the other leg and gradually involving more and more of body in terms of disability." That’s neurologist Bruce Cree of the University of California, San Francisco. He’s been testing a new drug in clinical trial that’s designed to reduce MS symptoms and found that patients’ brain inflammation was practically gone. "This was very impressive and suggests that we have a highly effective therapy. There is some advantage in medication in terms of tolerability, in terms of efficacy and I think it’s going to be a very important new therapy." The drug is called ocrelizumab and it’s currently under review by the Food and Drug Administration.
	Total Play:		0